The Challenge: Balancing Diabetes Control and Hypoglycemia Risk

  • Insulin remains the mainstay for glycemic control for patients with Type 1 diabetes and for people with Type 2 diabetes not controlled on non-insulin therapies
  • Insulin induced hypoglycemia is the primary obstacle to glycemic goal attainment
  • The majority of patients on insulin do not achieve their A1C targets
  • ~1.4M emergency hospital visits/hospitalizations per year (USA)Severe hypoglycemia occurs at all A1C levels

  • Severe hypoglycemia and its complications are costly

ABV100: A smart solution that fits well with current and future pharmacological and device platforms.

Trusted Partners & Research Collaborators